Integer (NYSE:ITGR) Given New $95.00 Price Target at Truist Financial

Integer (NYSE:ITGR) had its price target upped by Truist Financial from $86.00 to $95.00 in a research note published on Thursday, MarketBeat Ratings reports. They currently have a buy rating on the medical equipment provider’s stock.

A number of other equities analysts also recently weighed in on ITGR. Bank of America downgraded Integer from a “buy” rating to a “neutral” rating and set a $87.00 target price on the stock. in a research note on Friday, October 24th. Piper Sandler reduced their price objective on shares of Integer from $155.00 to $82.00 and set an “overweight” rating for the company in a research note on Friday, October 24th. Argus lowered Integer from a “buy” rating to a “hold” rating in a report on Friday, October 24th. Wells Fargo & Company reiterated an “equal weight” rating and set a $80.00 price objective (down from $132.00) on shares of Integer in a research report on Friday, October 24th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Integer in a report on Friday, October 31st. Four investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $98.38.

Integer Trading Up 6.0%

NYSE ITGR opened at $78.59 on Thursday. The company has a debt-to-equity ratio of 0.70, a current ratio of 3.71 and a quick ratio of 2.45. Integer has a one year low of $62.00 and a one year high of $146.36. The business has a 50 day simple moving average of $76.31 and a 200 day simple moving average of $99.02. The stock has a market capitalization of $2.75 billion, a P/E ratio of 32.88, a P/E/G ratio of 0.68 and a beta of 0.82.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, October 23rd. The medical equipment provider reported $1.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.68 by $0.11. Integer had a net margin of 4.75% and a return on equity of 12.84%. During the same quarter last year, the firm earned $1.43 EPS. The business’s revenue was up 8.4% compared to the same quarter last year. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. Research analysts expect that Integer will post 6.01 earnings per share for the current year.

Integer announced that its board has approved a stock repurchase plan on Tuesday, November 4th that allows the company to buyback $200.00 million in outstanding shares. This buyback authorization allows the medical equipment provider to purchase up to 8.3% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s board of directors believes its stock is undervalued.

Insider Activity at Integer

In other Integer news, Director Cheryl C. Capps purchased 1,600 shares of Integer stock in a transaction dated Thursday, November 6th. The stock was purchased at an average price of $66.70 per share, with a total value of $106,720.00. Following the transaction, the director directly owned 11,702 shares of the company’s stock, valued at $780,523.40. This trade represents a 15.84% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Payman Khales purchased 3,127 shares of the company’s stock in a transaction dated Thursday, October 30th. The shares were acquired at an average price of $64.94 per share, for a total transaction of $203,067.38. Following the purchase, the chief executive officer directly owned 22,865 shares in the company, valued at approximately $1,484,853.10. The trade was a 15.84% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders bought 5,843 shares of company stock worth $384,771. 2.16% of the stock is owned by insiders.

Hedge Funds Weigh In On Integer

Hedge funds have recently modified their holdings of the company. Emerald Advisers LLC increased its stake in Integer by 1,542.0% in the 2nd quarter. Emerald Advisers LLC now owns 103,824 shares of the medical equipment provider’s stock worth $12,767,000 after acquiring an additional 97,501 shares during the last quarter. Intech Investment Management LLC raised its holdings in shares of Integer by 92.8% in the first quarter. Intech Investment Management LLC now owns 22,682 shares of the medical equipment provider’s stock worth $2,677,000 after buying an additional 10,915 shares during the period. Dynamic Technology Lab Private Ltd purchased a new stake in shares of Integer during the first quarter valued at $916,000. Wakefield Asset Management LLLP bought a new stake in shares of Integer during the second quarter valued at approximately $1,118,000. Finally, Russell Investments Group Ltd. raised its holdings in shares of Integer by 14.7% in the first quarter. Russell Investments Group Ltd. now owns 6,749 shares of the medical equipment provider’s stock valued at $796,000 after acquiring an additional 863 shares in the last quarter. 99.29% of the stock is currently owned by institutional investors.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.